A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. [electronic resource]
Producer: 20150723Description: 728-36 p. digitalISSN:- 1523-6838
- Aged
- Anemia, Iron-Deficiency -- drug therapy
- Disease Progression
- Double-Blind Method
- Female
- Ferric Compounds -- therapeutic use
- Fibroblast Growth Factor-23
- Fibroblast Growth Factors -- blood
- Hematinics -- therapeutic use
- Humans
- Male
- Middle Aged
- Phosphates -- blood
- Renal Insufficiency, Chronic -- blood
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.